Observational studyInternational journal of clinical oncology2020

Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.

Toshikazu Moriwaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.